Aurobindo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?
AUROBINDO has five hundred approved drugs.
There are nineteen tentative approvals on AUROBINDO drugs.
Summary for Aurobindo
US Patents: | 0 |
Tradenames: | 378 |
Ingredients: | 351 |
NDAs: | 500 |
Patent Litigation for Aurobindo: | See patent lawsuits for Aurobindo |
PTAB Cases with Aurobindo as petitioner: | See PTAB cases with Aurobindo as petitioner |
Drugs and US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | SIMVASTATIN | simvastatin | TABLET;ORAL | 077691-002 | Dec 20, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 202050-002 | Apr 23, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 213544-002 | Mar 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 209081-001 | Dec 23, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | PREDNISONE | prednisone | TABLET;ORAL | 215672-002 | Mar 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090778-002 | Dec 11, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 090555-002 | Apr 7, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Sign Up |
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Sign Up |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.